Toward gene therapy of primary ovarian failure: Adenovirus expressing human FSH receptor corrects the Finnish C566T mutation

M. Ghadami, S. A. Salama, N. Khatoon, R. Chilvers, M. Nagamani, P. J. Chedrese, Ayman Al-Hendy

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Resistance ovarian syndrome is a heterogeneous disorder inherited as a Mendelian recessive trait and characterized by infertility, primary amenorrhea, normal karyotype and elevated serum FSH and LH levels. An inactivating mutation, C566T, in FSH receptor gene (FSHR) has been identified initially in Finland. We investigated if an adenovirus expressing a normal copy of human FSHR (Ad-hFSHR) has the ability to: (i) transfect granulosa cell lines, (ii) render the transfected cell lines responsive to FSH stimulation and (iii) transcomplement the malfunctioning form of human FSHR gene with C566T mutation. COS-7, JC-410, JC-410-P450-scc-luc and JC-410-StAR-luc cell lines were infected by Ad-hFSHR followed by treatment with FSH. Functional activity of the Ad-hFSHR was tested by measuring cyclic adenosine monophosphate (cAMP) or luciferase activity in response to FSH stimulation, and showed 2-4.6-fold increases in Ad-hFSHR transfected cells compared with untransfected or Ad-LacZ transfected cells, indicating that Ad-hFSHR is functionally active and expressing hFSHR. Generation of cAMP in cells expressing only mutated hFSHR-T566 showed minimal increase after FSH stimulation. Co-transfection of Ad-hFSHR in these cells carrying the malfunction form of human FSHR caused significant increases of 2.2-7.4-fold in FSH dependent cAMP generation (P = 0.0007). We concluded that adenovirus expressing a normal human FSHR can compensate the inactivating human FSHR-C566T mutation and restore FSH responsiveness.

Original languageEnglish (US)
Pages (from-to)9-15
Number of pages7
JournalMolecular Human Reproduction
Volume14
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Human Follicle Stimulating Hormone
FSH Receptors
Adenoviridae
Genetic Therapy
Mutation
Genes
Cyclic AMP
Cell Line
Granulosa Cells
Amenorrhea
Finland
Luciferases
Karyotype
Infertility
Transfection
Serum

Keywords

  • Finnish C566T mutation
  • Follicle-stimulating hormone receptor
  • Gene therapy of ovarian failure
  • Infertility
  • Primary amenorrhea

ASJC Scopus subject areas

  • Reproductive Medicine
  • Embryology
  • Molecular Biology
  • Genetics
  • Obstetrics and Gynecology
  • Developmental Biology
  • Cell Biology

Cite this

Ghadami, M., Salama, S. A., Khatoon, N., Chilvers, R., Nagamani, M., Chedrese, P. J., & Al-Hendy, A. (2008). Toward gene therapy of primary ovarian failure: Adenovirus expressing human FSH receptor corrects the Finnish C566T mutation. Molecular Human Reproduction, 14(1), 9-15. https://doi.org/10.1093/molehr/gam077

Toward gene therapy of primary ovarian failure : Adenovirus expressing human FSH receptor corrects the Finnish C566T mutation. / Ghadami, M.; Salama, S. A.; Khatoon, N.; Chilvers, R.; Nagamani, M.; Chedrese, P. J.; Al-Hendy, Ayman.

In: Molecular Human Reproduction, Vol. 14, No. 1, 01.01.2008, p. 9-15.

Research output: Contribution to journalArticle

Ghadami, M, Salama, SA, Khatoon, N, Chilvers, R, Nagamani, M, Chedrese, PJ & Al-Hendy, A 2008, 'Toward gene therapy of primary ovarian failure: Adenovirus expressing human FSH receptor corrects the Finnish C566T mutation', Molecular Human Reproduction, vol. 14, no. 1, pp. 9-15. https://doi.org/10.1093/molehr/gam077
Ghadami, M. ; Salama, S. A. ; Khatoon, N. ; Chilvers, R. ; Nagamani, M. ; Chedrese, P. J. ; Al-Hendy, Ayman. / Toward gene therapy of primary ovarian failure : Adenovirus expressing human FSH receptor corrects the Finnish C566T mutation. In: Molecular Human Reproduction. 2008 ; Vol. 14, No. 1. pp. 9-15.
@article{d6b18f5e048741e380211d6da55d03a9,
title = "Toward gene therapy of primary ovarian failure: Adenovirus expressing human FSH receptor corrects the Finnish C566T mutation",
abstract = "Resistance ovarian syndrome is a heterogeneous disorder inherited as a Mendelian recessive trait and characterized by infertility, primary amenorrhea, normal karyotype and elevated serum FSH and LH levels. An inactivating mutation, C566T, in FSH receptor gene (FSHR) has been identified initially in Finland. We investigated if an adenovirus expressing a normal copy of human FSHR (Ad-hFSHR) has the ability to: (i) transfect granulosa cell lines, (ii) render the transfected cell lines responsive to FSH stimulation and (iii) transcomplement the malfunctioning form of human FSHR gene with C566T mutation. COS-7, JC-410, JC-410-P450-scc-luc and JC-410-StAR-luc cell lines were infected by Ad-hFSHR followed by treatment with FSH. Functional activity of the Ad-hFSHR was tested by measuring cyclic adenosine monophosphate (cAMP) or luciferase activity in response to FSH stimulation, and showed 2-4.6-fold increases in Ad-hFSHR transfected cells compared with untransfected or Ad-LacZ transfected cells, indicating that Ad-hFSHR is functionally active and expressing hFSHR. Generation of cAMP in cells expressing only mutated hFSHR-T566 showed minimal increase after FSH stimulation. Co-transfection of Ad-hFSHR in these cells carrying the malfunction form of human FSHR caused significant increases of 2.2-7.4-fold in FSH dependent cAMP generation (P = 0.0007). We concluded that adenovirus expressing a normal human FSHR can compensate the inactivating human FSHR-C566T mutation and restore FSH responsiveness.",
keywords = "Finnish C566T mutation, Follicle-stimulating hormone receptor, Gene therapy of ovarian failure, Infertility, Primary amenorrhea",
author = "M. Ghadami and Salama, {S. A.} and N. Khatoon and R. Chilvers and M. Nagamani and Chedrese, {P. J.} and Ayman Al-Hendy",
year = "2008",
month = "1",
day = "1",
doi = "10.1093/molehr/gam077",
language = "English (US)",
volume = "14",
pages = "9--15",
journal = "Molecular Human Reproduction",
issn = "1360-9947",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Toward gene therapy of primary ovarian failure

T2 - Adenovirus expressing human FSH receptor corrects the Finnish C566T mutation

AU - Ghadami, M.

AU - Salama, S. A.

AU - Khatoon, N.

AU - Chilvers, R.

AU - Nagamani, M.

AU - Chedrese, P. J.

AU - Al-Hendy, Ayman

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Resistance ovarian syndrome is a heterogeneous disorder inherited as a Mendelian recessive trait and characterized by infertility, primary amenorrhea, normal karyotype and elevated serum FSH and LH levels. An inactivating mutation, C566T, in FSH receptor gene (FSHR) has been identified initially in Finland. We investigated if an adenovirus expressing a normal copy of human FSHR (Ad-hFSHR) has the ability to: (i) transfect granulosa cell lines, (ii) render the transfected cell lines responsive to FSH stimulation and (iii) transcomplement the malfunctioning form of human FSHR gene with C566T mutation. COS-7, JC-410, JC-410-P450-scc-luc and JC-410-StAR-luc cell lines were infected by Ad-hFSHR followed by treatment with FSH. Functional activity of the Ad-hFSHR was tested by measuring cyclic adenosine monophosphate (cAMP) or luciferase activity in response to FSH stimulation, and showed 2-4.6-fold increases in Ad-hFSHR transfected cells compared with untransfected or Ad-LacZ transfected cells, indicating that Ad-hFSHR is functionally active and expressing hFSHR. Generation of cAMP in cells expressing only mutated hFSHR-T566 showed minimal increase after FSH stimulation. Co-transfection of Ad-hFSHR in these cells carrying the malfunction form of human FSHR caused significant increases of 2.2-7.4-fold in FSH dependent cAMP generation (P = 0.0007). We concluded that adenovirus expressing a normal human FSHR can compensate the inactivating human FSHR-C566T mutation and restore FSH responsiveness.

AB - Resistance ovarian syndrome is a heterogeneous disorder inherited as a Mendelian recessive trait and characterized by infertility, primary amenorrhea, normal karyotype and elevated serum FSH and LH levels. An inactivating mutation, C566T, in FSH receptor gene (FSHR) has been identified initially in Finland. We investigated if an adenovirus expressing a normal copy of human FSHR (Ad-hFSHR) has the ability to: (i) transfect granulosa cell lines, (ii) render the transfected cell lines responsive to FSH stimulation and (iii) transcomplement the malfunctioning form of human FSHR gene with C566T mutation. COS-7, JC-410, JC-410-P450-scc-luc and JC-410-StAR-luc cell lines were infected by Ad-hFSHR followed by treatment with FSH. Functional activity of the Ad-hFSHR was tested by measuring cyclic adenosine monophosphate (cAMP) or luciferase activity in response to FSH stimulation, and showed 2-4.6-fold increases in Ad-hFSHR transfected cells compared with untransfected or Ad-LacZ transfected cells, indicating that Ad-hFSHR is functionally active and expressing hFSHR. Generation of cAMP in cells expressing only mutated hFSHR-T566 showed minimal increase after FSH stimulation. Co-transfection of Ad-hFSHR in these cells carrying the malfunction form of human FSHR caused significant increases of 2.2-7.4-fold in FSH dependent cAMP generation (P = 0.0007). We concluded that adenovirus expressing a normal human FSHR can compensate the inactivating human FSHR-C566T mutation and restore FSH responsiveness.

KW - Finnish C566T mutation

KW - Follicle-stimulating hormone receptor

KW - Gene therapy of ovarian failure

KW - Infertility

KW - Primary amenorrhea

UR - http://www.scopus.com/inward/record.url?scp=39449133687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39449133687&partnerID=8YFLogxK

U2 - 10.1093/molehr/gam077

DO - 10.1093/molehr/gam077

M3 - Article

C2 - 18084009

AN - SCOPUS:39449133687

VL - 14

SP - 9

EP - 15

JO - Molecular Human Reproduction

JF - Molecular Human Reproduction

SN - 1360-9947

IS - 1

ER -